Lincoln Pharma is not listed on NSE
AnnouncementsLincoln Pharmaceuticals recommends dividend
Only BuyersOnly Buyers in Lincoln Pharma on BSE
AnnouncementsLincoln Pharmaceuticals: Outcome of AGM
AnnouncementsLincoln Pharmaceuticals: Outcome of Board Meeting
AnnouncementsLincoln Pharmaceuticals board recommends dividend
AnnouncementsLincoln Pharma board to consider dividend
No recommendations so far.What's your call on Lincoln Pharma today?
|Company Name||Last Price||%
|Dr Reddys Labs||3229.00||0.68||3353.85||2420.00||55,011.13|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
Kwality Recommended on Jun 25th 2014
Recommended price 45.00 | Peak from reco 58.00 28.89%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Lincoln Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 83.35 crore.The company has reported a consolidated sales of Rs 46.95 crore and a Net Profit of Rs 3.04 crore for the quarter ended Jun 2014.
The company management includes Kishor M Shah - Chairman, Mahendra G Patel - Managing Director, Rajnikant G Patel - Joint Managing Director, Arvindbhai G Patel - Whole Time Director, Hasmukhbhai I Patel - Whole Time Director, Ishwarlal A Patel - Director, Maganbhai R Patel - Director, Pirabhai R Suthar - Director.
It is listed on the BSE with a BSE Code of 531633.
Its Registered office is at "Lincoln House", Behind Satyam Complex,,Science City Road, Ahmedabad,Gujarat - 380060.
Their Registrars are Sharepro Services (India) Pvt.Ltd.